Risk Management

Meridia withdrawal has raised issue issue of sibutramine contamination

Wall Street Journal raises subatramine contamination question

By Shane Starling

Following last Friday’s decision by Abbott Laboratories to pull its sibutramine-containing weight loss drug Meridia due to concerns about side effects, questions are being asked about dietary supplement contamination with the substance.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All